Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Operations: 2011-2025

Historic Cash from Operations for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to -$88,000.

  • Sonoma Pharmaceuticals' Cash from Operations rose 20.55% to -$1.0 million in Q1 2013 from the same period last year, while for Mar 2013 it was $1.1 million, marking a year-over-year increase of 128.52%. This contributed to the annual value of -$88,000 for FY2025, which is 96.33% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Cash from Operations stood at -$88,000 for FY2025, which was up 96.33% from -$2.4 million recorded in FY2024.
  • Sonoma Pharmaceuticals' Cash from Operations' 5-year high stood at -$88,000 during FY2025, with a 5-year trough of -$6.2 million in FY2023.
  • In the last 3 years, Sonoma Pharmaceuticals' Cash from Operations had a median value of -$2.4 million in 2024 and averaged -$2.9 million.
  • In the last 5 years, Sonoma Pharmaceuticals' Cash from Operations slumped by 44.82% in 2023 and then surged by 96.33% in 2025.
  • Sonoma Pharmaceuticals' Cash from Operations (Yearly) stood at -$3.4 million in 2021, then dropped by 25.75% to -$4.2 million in 2022, then plummeted by 44.82% to -$6.2 million in 2023, then spiked by 61.02% to -$2.4 million in 2024, then skyrocketed by 96.33% to -$88,000 in 2025.